Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on April 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …

Comscore Secures Multi-Season Agreement with The Summit League
RESTON, Va., April 16, 2025 (GLOBE NEWSWIRE) -- Comscore (Nasdaq: SCOR), a global leader in measuring and analyzing consumer behaviors, today announced a multi-season national and local TV measurement agreement with The Summit League, an NCAA Division I …

CUSIP Request Volumes for New Corporate Debt and Equity Instruments Increase in March
NORWALK, Conn., April 16, 2025 (GLOBE NEWSWIRE) -- CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for March 2025. The report, which tracks the issuance of new security identifiers as an early indicator of debt …

Alpha Modus Holdings Inc. (NASDAQ: AMOD) Shareholder Letter
CORNELIUS, N.C., April 16, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, Since our public debut through the successful completion of our DeSPAC transaction, Alpha Modus has remained unwavering in its mission to drive long-term shareholder value through the …

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this quarter or in the third quarter LITTLETON, …

Progressive Reports March 2025 Results
MAYFIELD VILLAGE, OHIO, April 16, 2025 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended March 31, 2025: March Quarter (millions, except per share amounts and ratios; unaudited …

Healthy Horizons CEO and COO Recognized for Maternal Health and STEM Advocacy with Stevie® Awards
Healthy Horizons Wins Dual Stevie® Awards In 2024 Stevie Awards For Women In Business SAN FRANCISCO, CA, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Healthy Horizons is thrilled to announce that CEO Sheila Janakos, MPH, IBCLC, LE, RLC, and COO …

New Jersey Turnpike Authority Affirms its Selection of TransCore to Improve E-ZPass Services
NASHVILLE, Tenn., April 16, 2025 (GLOBE NEWSWIRE) -- TransCore, a leading provider of advanced tolling and traffic management solutions, announced today that the New Jersey Turnpike Authority (NJTA) has affirmed its decision to award TransCore E-ZPass …

Onfolio Holdings Inc. Announces Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
WILMINGTON, Del., April 16, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) ("Onfolio" or the "Company"), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of …

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April 23, …

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine …

Terra Balcanica Announces LIFE Offering
Vancouver, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce that it intends to complete a non-brokered, listed issuer financing exemption private …

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™
MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes, is re-issuing an amended version of its April 10th, 2025, press …

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™
MONTRÉAL, 16 avr. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés réédite une version modifiée de son communiqué du …

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before …

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for the treatment of solid tumors Platform technology to fuel …

La Rosa Holdings Corp. Reports 119% Year-Over-Year Increase in Revenue to $69.4 Million for Fiscal 2024; Surpassed Initial Revenue Guidance by Approximately $4.4 Million
Revenue for the Fourth Quarter of 2024 Increased 55% Year-Over-Year to $17.7 Million Gross Profit Increased 110% Year-Over-Year to $6.0 Million in 2024 CELEBRATION, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” …

Avicanna Announces Revocation of Management Cease Trade Order
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …